Fig. 1From: Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in SpainKaplan-Meier curves for progression-free survival (a) and overall survival (b) for EGFR TKI-treated patients carrying common and rare EGFR sensitising mutations and Kaplan-Meier curves for progression-free survival (c) and overall survival (d) for patients treated with an EGFR TKI harbouring exon 19 deletions or L858R point mutations. CI: Confidence interval; NE: Not evaluable; OS: Overall survival; PFS: Progression-free survivalBack to article page